INTERNATIONAL PATENT: PFIZER INC. FILES APPLICATION FOR "HETEROCYCLIC COMPOUNDS AS GLUCOSE-DEPENDENT INSULINOTROPIC POLYPEPTIDE RECEPTOR ANTAGONISTS"

GENEVA, April 18 -- PFIZER INC. (66 Hudson Boulevard EastNew York, New York 10001-2192) filed a patent application (PCT/IB2025/060385) for "HETEROCYCLIC COMPOUNDS AS GLUCOSE-DEPENDENT INSULINOTROPIC POLYPEPTIDE RECEPTOR ANTAGONISTS" on Oct 13, 2025. With publication no. WO/2026/078671, the details related to the patent application was published on Apr 16, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): FILIPSKI, Kevin James (c/o Pfizer Inc.610 Main StreetCambridge, Massachusetts 02139), WANG, Yang (c/o Pfizer Inc.610 Main StreetCambridge, Massachusetts 02139)

Abstract: Described herein are ...